COVID-19 vaccine Update Live: Dr Reddy's gets DCGI's approval to conduct human trials for Russia's Sputnik V.
  • 3 years ago
Coronavirus vaccine news: The government said on Sunday that Pune’s Serum Institute of India and Hyderabad’s Bharat Biotech will soon begin the late-stage clinical trials of the nasal Covid-19 vaccine in India.

Dr. Reddy's Laboratories Ltd. and Russian Direct Investment Fund have received approval from the Drug Control General of India (DCGI) to conduct phase 2/3 human clinical trial for Sputnik V vaccine in India.





#TazaWorldNews
#CoronavirusVaccine
#CoronavirusUpdate
#HumanTrials
#HumanClinicalTrial
#DrReddy
Recommended